(0.05%) 5 519.75 points
(0.11%) 39 889 points
(0.14%) 19 779 points
(-0.06%) $81.58
(0.64%) $2.83
(-0.27%) $2 338.00
(0.08%) $29.55
(0.37%) $1 005.50
(0.08%) $0.932
(-0.07%) $10.53
(0.00%) $0.788
(-0.85%) $87.25
-0.71% $ 15.38
Live Chart Being Loaded With Signals
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction...
Stats | |
---|---|
Dzisiejszy wolumen | 46 207 |
Średni wolumen | 46 056 |
Kapitalizacja rynkowa | 183.67M |
EPS | $0.0863 ( Q1 | 2024-03-31 ) |
Następna data zysków | ( $-1.000 ) 2024-08-12 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0610 (0.39%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-25 | Alloway Paul | Sell | 268 | Common Stock |
2024-03-25 | Michaud Charles Jr | Sell | 75 | Common Stock |
2024-03-25 | Tzianabos Arthur | Buy | 12 767 | Stock Option (Right to Buy) |
2024-03-25 | Manke Isaac | Buy | 12 767 | Stock Option (Right to Buy) |
2024-03-25 | Iwicki Mark T | Buy | 25 534 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
49.74 |
Last 27 transactions |
Buy: 797 771 | Sell: 267 800 |
Wolumen Korelacja
Q32 Bio Inc. Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Q32 Bio Inc. Korelacja - Waluta/Towar
Q32 Bio Inc. Finanse
Annual | 2023 |
Przychody: | $1.16M |
Zysk brutto: | $578 000 (50.00 %) |
EPS: | $-35.16 |
FY | 2023 |
Przychody: | $1.16M |
Zysk brutto: | $578 000 (50.00 %) |
EPS: | $-35.16 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Q32 Bio Inc.
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body’s first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32’s complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej